Nilsen Hilde, Lindahl Tomas, Verreault Alain
Mutagenesis and Chromosome Dynamics Laboratories, Clare Hall Laboratories, Cancer Research UK.
EMBO J. 2002 Nov 1;21(21):5943-52. doi: 10.1093/emboj/cdf581.
The human base excision repair machinery must locate and repair DNA base damage present in chromatin, of which the nucleosome core particle is the basic repeating unit. Here, we have utilized fragments of the Lytechinus variegatus 5S rRNA gene containing site-specific U:A base pairs to investigate the base excision repair pathway in reconstituted nucleosome core particles in vitro. The human uracil-DNA glycosylases, UNG2 and SMUG1, were able to remove uracil from nucleosomes. Efficiency of uracil excision from nucleosomes was reduced 3- to 9-fold when compared with naked DNA, and was essentially uniform along the length of the DNA substrate irrespective of rotational position on the core particle. Furthermore, we demonstrate that the excision repair pathway of an abasic site can be reconstituted on core particles using the known repair enzymes, AP-endonuclease 1, DNA polymerase beta and DNA ligase III. Thus, base excision repair can proceed in nucleosome core particles in vitro, but the repair efficiency is limited by the reduced activity of the uracil-DNA glycosylases and DNA polymerase beta on nucleosome cores.
人类碱基切除修复机制必须定位并修复染色质中存在的DNA碱基损伤,而核小体核心颗粒是其基本重复单元。在此,我们利用含有位点特异性U:A碱基对的长刺海胆5S rRNA基因片段,在体外重构的核小体核心颗粒中研究碱基切除修复途径。人类尿嘧啶-DNA糖基化酶UNG2和SMUG1能够从核小体中去除尿嘧啶。与裸露DNA相比,从核小体中切除尿嘧啶的效率降低了3至9倍,并且沿着DNA底物的长度基本一致,与核心颗粒上的旋转位置无关。此外,我们证明可以使用已知的修复酶,即脱嘌呤嘧啶内切酶1、DNA聚合酶β和DNA连接酶III,在核心颗粒上重构无碱基位点的切除修复途径。因此,碱基切除修复可以在体外的核小体核心颗粒中进行,但修复效率受到尿嘧啶-DNA糖基化酶和DNA聚合酶β在核小体核心上活性降低的限制。